The Alaska Immunization Program formed a new HPV joint initiative workgroup to provide input on HPV PPHF grant activities and increase collaboration across partners related to increasing HPV immunization rates.
The Michigan Immunization Program is currently planning strategies for sustaining its HPV stakeholder group now that the HPV-specifc Prevention and Public Health Fund (PPHF) funding period is over.
The Minnesota Immunization Program worked with the Minnesota State High School League to update language related to vaccines on their standard pre-participation sports physical examination form.
To engage community and healthcare partners in an Idaho Statewide Cancer Prevention activity, an HPV Vaccination Day was held in February 2017. The purpose of the statewide HPV Vaccination Day was to raise awareness among parents of adolescents and create…
[2018 Bull’s-Eye Award Winner!] After identifying a gap of HPV first dose coverage among 11-12-year-olds, The New Jersey Immunization Program developed an approach to assist healthcare providers to quickly and easily assess how well they are administering HPV first dose…
The Washington State Department of Health Office of Immunization and Child Profile provided funding to external partners to support development of HPV immunization campaign messages targeting two at-risk subpopulations of adolescents and young adults
The New Jersey Department of Health and Senior Services Vaccine Preventable Disease Program, together with the Partnership for Maternal and Child Health of Northern New Jersey (PMCHNNJ), developed and implemented a multi-pronged adolescent immunization awareness initiative that includes an annual…
The Alabama Department of Public Health (ADPH) partnered with the Alabama State Department of Education (ALSDE) to give public schools the ability to print valid Certificates of Immunization for their students directly from the state immunization information system (IIS).
The New York State Department of Health mailed centralized reminder recall letters statewide (excluding NYC) to parents and guardians of boys and girls ages 11-13 years old who had either initiated but not yet completed the HPV vaccine series or…